ArticleEye (London, England)2026
Association of accelerometer-monitored physical activity with incident cataract: epidemiological and genetic evidence.
Article in Eye (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
purposeTo investigate the association and potential causal relationship between accelerometer-assessed physical activity (PA) and the risk of senile cataract (SC).
methodsThe study population was derived from the UK Biobank database. Triaxial accelerometer data from wearable devices, collected over a continuous 7-day wear period (accounting for potential seasonal variation), were used to define PA at light (LPA), moderate (MPA), and vigorous (VPA) intensities. Multivariable Cox proportional hazards models were used to examine the association between PA intensity-specific domains and SC incidence. Furthermore, two-sample Mendelian randomisation (MR) analyses were conducted using genome-wide association data from multiple large-scale prospective study cohorts (UK Biobank for PA and FinnGen for SC) to elucidate potential causality.
resultsThe study ultimately enrolled 77,123 participants with a mean age of 55.67 ± 7.8 years. During a mean follow-up of 6.3 years (interquartile range [IQR]: 5.3-7.3 years), 1194 incident SC cases were identified. Compared with insufficient activity, achieving 150-600 min of moderate to vigorous-intensity PA (MVPA) per week was associated with a 21% lower risk of SC (HR = 0.79, 95% CI: 0.68-0.91). Dose-response analyses revealed U-shaped associations for MPA and MVPA, with the lowest risk observed at moderate volumes. For other intensities, engaging in ≥300 min/week of MPA was associated with reduced risk (HR = 0.78, 95% CI: 0.66-0.92), while no significant associations were observed for LPA or VPA alone. MR analysis supported a causal relationship, indicating that genetically proxied higher MVPA was associated with a lower risk of SC (OR = 0.56, 95% CI: 0.38-0.83, P = 0.004).
conclusionAdhering to the PA guidelines established by the World Health Organization emerges as a novel and modifiable protective measure to delay the progression of SC.
Identifiers
42493575What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.